Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director/PDMR Shareholding

19 Dec 2016 17:01

RNS Number : 2836S
Chamberlin PLC
19 December 2016
 



 

 

Chamberlin plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulation)

Walsall, UK, 19 December 2016: Chamberlin plc (LSE: CMH; "Chamberlin" or "the Company") confirms that on 19 December 2016, the following Persons Discharging Managerial Responsibility ("PDMR") were granted nil cost options by the Company over ordinary shares of 25 pence each in Chamberlin plc under the Company's Performance Share Plan, as set out below:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kevin Nolan

2

Reason for Notification

a)

Position/status

Chief Executive

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chamberlin plc

b)

LEI

13800OS2SK73PPFO761

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25 pence each in Chamberlin plc

 

GB0001870228

b)

Nature of the transaction

Grant of nil cost options by the Company under the Company's Performance Share Plan. Subject to a performance condition and continued service, normally vests after 3 years.

The performance condition is based on the Company's share price at the end of the performance period, with 20% of the total award vesting at a price of 80 pence per share and 100% of the total award vesting at a price of 120 pence per share. If the share price is between 80 pence and 120 pence at the end of the performance period, then the number options that vest shall be calculated on a straight line basis between 20% and 100% of the entitlement, with no options vesting if the price is less than 80 pence per share.

c)

Price(s) andvolume(s)

Price(s)

Volume(s)

Nil

207,363

d)

Aggregated information

-Aggregated volume

- Price

 

 

N/A

 

e)

Date of the transaction

19 December 2016

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Roberts

2

Reason for Notification

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chamberlin plc

b)

LEI

13800OS2SK73PPFO761

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25 pence each in Chamberlin plc

 

GB0001870228

b)

Nature of the transaction

Grant of nil cost options by the Company under the Company's Performance Share Plan. Subject to a performance condition and continued service, normally vests after 3 years.

The performance condition is based on the Company's share price at the end of the performance period, with 20% of the total award vesting at a price of 80 pence per share and 100% of the total award vesting at a price of 120 pence per share. If the share price is between 80 pence and 120 pence at the end of the performance period, then the number options that vest shall be calculated on a straight line basis between 20% and 100% of the entitlement, with no options vesting if the price is less than 80 pence per share.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

142,637

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

 

e)

Date of the transaction

19 December 2016

f)

Place of the transaction

Outside a trading venue

Following the above transactions, Mr Nolan's and Mr Roberts' respective interests are in 569,558 options and 380,442 options granted over ordinary shares of 25 pence each in the Company.

Enquiries:

Chamberlin plc

Kevin Nolan, Chief Executive

David Roberts, Finance Director

T: 01922 707100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHTLBFTMBJBBBF
Date   Source Headline
5th Jun 201811:45 amEQSHardman & Co Research: Chamberlin pLC (CMH): Trading strong, technical issues largely resolved
5th Jun 20187:00 amRNSFinal Results
9th May 20186:05 pmRNSHolding(s) in Company
9th May 20184:30 pmRNSHolding(s) in Company
9th May 20184:30 pmRNSHolding(s) in Company
12th Apr 20187:00 amRNSTrading Update
26th Mar 20187:00 amRNSBoard Appointment
22nd Jan 20187:00 amRNSMachining claim update
6th Dec 20177:00 amRNSDirectors' Interests
1st Dec 20177:00 amRNSBoard Change
28th Nov 20177:00 amRNSHalf-year Results
18th Oct 20177:00 amRNSTrading Update
20th Jul 201711:48 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
5th Jun 20177:00 amRNSHolding(s) in Company
23rd May 20177:00 amRNSFinal Results
11th Apr 20177:00 amRNSTrading Update
23rd Mar 20177:00 amRNSNew Machining Facility Open Day
21st Mar 20172:24 pmRNSHardman Research: Turbo-charging into growth phase
10th Jan 20172:15 pmRNSAppointment of new Nominated Adviser and Broker
19th Dec 20165:01 pmRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSHalf-year Report
21st Nov 20167:00 amRNSTrading update
27th Sep 20161:50 pmRNSHolding(s) in Company
8th Aug 201612:43 pmRNSHolding(s) in Company
22nd Jul 20162:24 pmRNSResult of AGM
22nd Jul 20167:00 amRNSAGM Statement
18th Jul 20167:00 amRNSBoard Appointment
29th Jun 20167:00 amRNSPromoted to Category "A" supplier by IHI
24th May 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSTrading Update, New Contract & New Facility
26th Jan 20164:26 pmRNSHolding(s) in Company
26th Jan 20161:19 pmRNSHolding(s) in Company
5th Jan 20161:26 pmRNSHolding(s) in Company
1st Dec 201510:03 amRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSHalf Yearly Report
6th Aug 20157:00 amRNSChange of Adviser
4th Aug 20153:58 pmRNSHolding(s) in Company
17th Jul 20155:07 pmRNSResult of AGM
17th Jul 20157:00 amRNSAGM Statement
19th May 20157:00 amRNSFinal Results
27th Nov 20144:50 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Results
18th Nov 20147:00 amRNSMajor Contract Win
17th Oct 20147:00 amRNSMajor contract win
14th Oct 20147:00 amRNSChange of Auditor
8th Aug 20143:21 pmRNSDirector/PDMR Shareholding
1st Aug 20149:00 amRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
20th May 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.